MedPath

Abbvie Corporation

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

275

CANADA:137
NMPA:1

Drug Approvals

Glecaprevir and Pibrentasvir Tablets

Product Name
艾诺全
Approval Number
H20190035
Approval Date
May 15, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.